BRITTANY WRAY: Open Payments
NPI 1740026012 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 26 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
| TerSera Therapeutics LLC | 1 | $31 |
| Lilly USA, LLC | 2 | $28 |
| Genentech USA, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Iovance Biotherapeutics, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
Products named: LYNOZYFIC, BRUKINSA, Zoladex, VERZENIO, Polivy, Enhertu, Amtagvi, Onivyde.
Industry payments across NE — which companies pay providers there.
